Search results
4 days ago · Eli Lilly & Co.’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the mind-robbing disease that afflicts 6 million Americans. It’s a big win for Lilly and...
3 days ago · Get a real-time Eli Lilly and Company (LLY) stock price quote with breaking news, financials, statistics, charts and more.
4 days ago · The approval Tuesday of Eli Lilly ’s LLY -1.85% new Alzheimer’s drug will hasten the transformation of treatment of the dementia-causing condition. Until recently, Alzheimer’s treatment was...
4 days ago · Eli Lilly & Co.’s Alzheimer’s treatment was cleared in the US as the second drug to slow progression of the mind-robbing disease that afflicts 6 million Americans.
4 days ago · After turning down Eli Lilly’s Alzheimer’s disease drug donanemab for an accelerated approval last year, the agency has now offered the anti-amyloid therapy—and a competitor to Eisai and Bioge.
4 days ago · Eli Lilly is gearing up to launch its Alzheimer’s drug for use in early-stage patients after receiving US approval on Tuesday, offering the medicine at a steep premium to a competitor as it...
4 days ago · Statement of changes in beneficial ownership of securities. July 1, 2024. 0001415889-24-018572.pdf. 0001415889-24-018572.rtf. 0001415889-24-018572.xls. View HTML. 144. Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing.